NCT02546661 2025-12-29
BISCAY
AstraZeneca
Phase 1 Active not recruiting
Clinical Trials
7 trialsNCT05775874 2023-03-20
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
Abbisko Therapeutics Co, Ltd
Phase 2 Unknown
NCT05086666 2021-10-21
A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Abbisko Therapeutics Co, Ltd
Phase 1/2 Unknown
NCT00979134 2019-03-15
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
AstraZeneca
Phase 1 Terminated
NCT01457846 2017-03-07
SHINE
AstraZeneca
Phase 2 Terminated
NCT01213160 2016-06-29
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
AstraZeneca
Phase 1 Completed
NCT01202591 2016-02-11
GLOW
AstraZeneca
Phase 1/2 Completed